Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |